majority of rare diseases
rare disease mechanisms
investigation of rare diseases able
personalized Medicine
chip technology needs
patient-specific fundamentals of diseases
personalized drug screening
organ-level functions
drug discovery
new drug
induced pluripotent Stem cell Technology
human models
precision medicine
engineering organ
Microfluidic technology
industrial level
academic level
development of novel human systems
pluripotent stem cells
patient-matched manner
affected patients
effective treatment
chronic health problems
novel miniaturized platform
CISTEM RISE project
number of so-called orphan drugs
major public health priority
burning issues
tailored micro-environment architecture
iPSCs
superb source
powerful tool
strong potential
synergies
quality of life
work packages
partners
Organs
Heart
variability
targeted secondments of staff
complementary expertise
promising research directions
impact
date
children